PPBT
Purple BiotechNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.49M
P/E Ratio
—
EPS
$-48.59
Beta
-0.54
52W High
$24.00
52W Low
$1.16
50-Day MA
$1.69
200-Day MA
$4.68
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Purple Biotech
Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United States. The company is headquartered in Rehovot, Israel.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | -59,000 |
| EBITDA | $-7.84M |
| Operating Margin | 0.00% |
| Return on Equity | -111.10% |
| Return on Assets | -20.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $10.00 |
| Price-to-Book | 0.20 |
| Price-to-Sales (TTM) | 58.08 |
| EV/Revenue | 33.07 |
| EV/EBITDA | -0.15 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $1.63M |
| Float | $1.08M |
| % Insiders | 3.73% |
| % Institutions | 7.10% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
Analyst Ratings
Consensus ($17.00 target)
1
BuyTurn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on PPBT and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 8/18/2026